Interact to see
Advertisement
Advertisement
NRGEX vs SSDIX
NRGEX vs SSDIX Comparison
Open Charts NRGEX vs SSDIX
Neuberger Berman Genesis E
Price$64.16
Change-$0.59 (-0.91%)
VolumeN/A
Net Assets9.11B
DWS Small Cap Growth Inst
Price$37.13
Change-$0.08 (-0.21%)
VolumeN/A
Net Assets263.43M
NRGEX vs SSDIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
FUNDAMENTALS
Fundamentals
NRGEX has more cash in the bank: 9.11B vs. SSDIX (263M). NRGEX pays higher dividends than SSDIX: NRGEX (0.54) vs SSDIX (0.00). NRGEX was incepted earlier than SSDIX: NRGEX (4 years) vs SSDIX (21 years). SSDIX (0.98) is less costly to investors than NRGEX (0.69). NRGEX is a more actively managed with annual turnover of: 13.00 vs. SSDIX (4.00). NRGEX has a lower initial minimum investment than SSDIX: NRGEX (0) vs SSDIX (1000000). SSDIX annual gain was more profitable for investors over the last year : 2.48 vs. NRGEX (-2.66).
| NRGEX | SSDIX | NRGEX / SSDIX | |
| Total Expense Ratio | 0.03 | 0.98 | 3% |
| Annual Report Gross Expense Ratio | 0.69 | 0.98 | 70% |
| Fund Existence | 4 years | 21 years | - |
| Gain YTD | -2.076 | 4.651 | -45% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 1000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 9.11B | 263M | 3,464% |
| Annual Yield % from dividends | 0.54 | 0.00 | - |
| Returns for 1 year | -2.66 | 2.48 | -107% |
| Returns for 3 years | -2.78 | 11.67 | -24% |
| Returns for 5 years | N/A | 15.20 | - |
| Returns for 10 years | N/A | 12.52 | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PAWZ | 57.83 | 0.07 | +0.12% |
| ProShares Pet Care ETF | |||
| FCBD | 25.59 | 0.01 | +0.05% |
| Frontier Asset Core Bond ETF | |||
| AWF | 11.12 | -0.05 | -0.45% |
| ALLIANCEBERSTEIN GLOBAL HIGH Income FUND | |||
| ISCB | 60.85 | -0.34 | -0.56% |
| iShares Morningstar Small-Cap ETF | |||
| BIS | 14.27 | -0.28 | -1.93% |
| ProShares UltraShort Nasdaq Biotech | |||